In 2016, we established a management policy that embraces the rich potential of bio-ventures, research institutes, academics, etc. through Open Innovation. Hanmi’s Open Innovation not only aims to discover new pipelines but also reflects our will to contribute to Korea’s development into a pharmaceutical power through rich experiences, know-how and capital sharing.